BAJAJ BROKING

Notification close image
No new Notification messages
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

532067

3BBLACKBIO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

3B BlackBio Dx Limited Share Price Update

As of the latest trading session, 3B BlackBio Dx Limited share price is currently at ₹ 1425.85, which is up by ₹ 2.69 from its previous closing. Today, the stock has fluctuated between ₹ 1421.05 and ₹ 1436.95. Over the past year, 3B BlackBio Dx Limited has achieved a return of -1.44 %. In the last month alone, the return has been -8.46 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

3B BlackBio Dx Limited fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    1,223.80

  • P/E Ratio (TTM)

    24.82

  • Beta

    0.58

  • Book Value / share

    317.85

  • Return on equity

    16.14%

  • EPS (TTM)

    57.44

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    12.46

info icon alternate text

3B BlackBio Dx Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 20.36
Operating Expense 8.99
Net Profit 12.46
Net Profit Margin (%) 61.19
Earnings Per Share (EPS) 14.54
EBITDA 15.91
Effective Tax Rate (%) 20.53
Particulars MAR 2025 (Values in Cr)
Revenue 23.02
Operating Expense 13.78
Net Profit 9.24
Net Profit Margin (%) 40.13
Earnings Per Share (EPS) 10.79
EBITDA 14.37
Effective Tax Rate (%) 34.65
Particulars DEC 2024 (Values in Cr)
Revenue 23.43
Operating Expense 8.70
Net Profit 13.45
Net Profit Margin (%) 57.40
Earnings Per Share (EPS) 15.70
EBITDA 17.97
Effective Tax Rate (%) 24.13
Particulars SEP 2024 (Values in Cr)
Revenue 26.57
Operating Expense 11.72
Net Profit 14.14
Net Profit Margin (%) 53.21
Earnings Per Share (EPS) 16.51
EBITDA 18.52
Effective Tax Rate (%) 22.60
Particulars JUN 2024 (Values in Cr)
Revenue 17.51
Operating Expense 7.39
Net Profit 10.73
Net Profit Margin (%) 61.27
Earnings Per Share (EPS) 12.53
EBITDA 14.02
Effective Tax Rate (%) 22.18
Particulars MAR 2025 (Values in Cr)
Revenue 90.53
Operating Expense 41.63
Net Profit 47.56
Net Profit Margin (%) 52.53
Earnings Per Share (EPS) 55.51
EBITDA 64.89
Effective Tax Rate (%) 25.60
Particulars MAR 2024 (Values in Cr)
Revenue 70.72
Operating Expense 36.58
Net Profit 34.21
Net Profit Margin (%) 48.37
Earnings Per Share (EPS) 39.93
EBITDA 47.41
Effective Tax Rate (%) 26.33
Particulars MAR 2023 (Values in Cr)
Revenue 59.34
Operating Expense 30.75
Net Profit 26.42
Net Profit Margin (%) 44.52
Earnings Per Share (EPS) 35.27
EBITDA 36.84
Effective Tax Rate (%) 26.28
Particulars MAR 2022 (Values in Cr)
Revenue 15.52
Operating Expense 17.16
Net Profit 8.01
Net Profit Margin (%) 51.61
Earnings Per Share (EPS) 10.67
EBITDA 8.86
Effective Tax Rate (%) 5.43
Particulars MAR 2021 (Values in Cr)
Revenue 14.36
Operating Expense 16.00
Net Profit 1.72
Net Profit Margin (%) 11.97
Earnings Per Share (EPS) 2.29
EBITDA 2.51
Effective Tax Rate (%) 17.78
Particulars MAR 2024 (Values in Cr)
Book Value / Share 260.32
ROE % 15.42
ROCE % 21.20
Total Debt to Total Equity 0.01
EBITDA Margin 61.40
Particulars MAR 2023 (Values in Cr)
Book Value / Share 225.60
ROE % 14.98
ROCE % 20.24
Total Debt to Total Equity 0.01
EBITDA Margin 58.81
Particulars MAR 2022 (Values in Cr)
Book Value / Share 204.26
ROE % 22.59
ROCE % 29.92
Total Debt to Total Equity 0.02
EBITDA Margin 54.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 176.27
ROE % 138.73
ROCE % 179.45
Total Debt to Total Equity 0.03
EBITDA Margin 67.43
Particulars MAR 2020 (Values in Cr)
Book Value / Share 42.87
ROE % 28.16
ROCE % 32.28
Total Debt to Total Equity 0.18
EBITDA Margin 37.82
Particulars MAR 2024 (Values in Cr)
Book Value / Share 265.84
ROE % 16.14
ROCE % 21.82
Total Debt to Total Equity 0.01
EBITDA Margin 67.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 228.91
ROE % 24.01
ROCE % 32.09
Total Debt to Total Equity 0.02
EBITDA Margin 62.08
Particulars MAR 2022 (Values in Cr)
Book Value / Share 31.94
ROE % 34.39
ROCE % 33.57
Total Debt to Total Equity 0.10
EBITDA Margin 57.09
Particulars MAR 2021 (Values in Cr)
Book Value / Share 30.24
ROE % 7.92
ROCE % 9.48
Total Debt to Total Equity 0.13
EBITDA Margin 17.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 27.74
ROE % 3.34
ROCE % 4.07
Total Debt to Total Equity 0.27
EBITDA Margin 8.59
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 62.14
Total Assets 248.10
Total Liabilities 248.10
Total Equity 225.47
Share Outstanding 8582670
Price to Book Ratio 2.89
Return on Assets (%) 12.93
Return on Capital (%) 14.18
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 59.20
Total Assets 214.05
Total Liabilities 214.05
Total Equity 195.91
Share Outstanding 8582670
Price to Book Ratio 1.82
Return on Assets (%) 12.11
Return on Capital (%) 13.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 28.89
Total Assets 192.09
Total Liabilities 192.09
Total Equity 172.07
Share Outstanding 7508100
Price to Book Ratio 10.68
Return on Assets (%) 16.76
Return on Capital (%) 18.44
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 35.07
Total Assets 193.52
Total Liabilities 193.52
Total Equity 148.27
Share Outstanding 7508100
Price to Book Ratio 9.41
Return on Assets (%) 58.83
Return on Capital (%) 75.77
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 9.38
Total Assets 44.83
Total Liabilities 44.83
Total Equity 34.25
Share Outstanding 7508100
Price to Book Ratio 2.62
Return on Assets (%) 17.14
Return on Capital (%) 20.35
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 54.87
Total Assets 249.82
Total Liabilities 249.82
Total Equity 227.78
Share Outstanding 8582670
Price to Book Ratio 2.89
Return on Assets (%) 13.69
Return on Capital (%) 14.97
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 50.35
Total Assets 213.66
Total Liabilities 213.66
Total Equity 196.09
Share Outstanding 8582670
Price to Book Ratio 1.82
Return on Assets (%) 12.36
Return on Capital (%) 13.34
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.85
Total Assets 31.60
Total Liabilities 31.60
Total Equity 23.92
Share Outstanding 7508100
Price to Book Ratio 10.68
Return on Assets (%) 25.33
Return on Capital (%) 30.26
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.70
Total Assets 28.88
Total Liabilities 28.88
Total Equity 22.65
Share Outstanding 7508100
Price to Book Ratio 9.41
Return on Assets (%) 5.94
Return on Capital (%) 6.97
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.68
Total Assets 28.16
Total Liabilities 28.16
Total Equity 20.78
Share Outstanding 7508100
Price to Book Ratio 2.62
Return on Assets (%) 2.17
Return on Capital (%) 2.53
Particulars MAR 2024 (Values in Cr)
Net Income 44.33
Cash from Operations 37.79
Cash from Investing -20.31
Cash from Financing -3.62
Net change in Cash 3.00
Free Cash Flow 38.29
Particulars MAR 2023 (Values in Cr)
Net Income 35.30
Cash from Operations 29.22
Cash from Investing 14.73
Cash from Financing -5.00
Net change in Cash 30.01
Free Cash Flow 31.25
Particulars MAR 2022 (Values in Cr)
Net Income 43.22
Cash from Operations 47.88
Cash from Investing -28.44
Cash from Financing -15.07
Net change in Cash -6.18
Free Cash Flow 50.15
Particulars MAR 2021 (Values in Cr)
Net Income 152.03
Cash from Operations 135.40
Cash from Investing -70.25
Cash from Financing -1.56
Net change in Cash 25.69
Free Cash Flow 137.08
Particulars MAR 2020 (Values in Cr)
Net Income 10.04
Cash from Operations 9.45
Cash from Investing -0.63
Cash from Financing 0.80
Net change in Cash 7.21
Free Cash Flow 9.98
Particulars MAR 2024 (Values in Cr)
Net Income 46.44
Cash from Operations 39.30
Cash from Investing -20.31
Cash from Financing -3.61
Net change in Cash 4.52
Free Cash Flow 39.81
Particulars MAR 2023 (Values in Cr)
Net Income 35.84
Cash from Operations 30.14
Cash from Investing -7.80
Cash from Financing -2.89
Net change in Cash 10.46
Free Cash Flow 31.10
Particulars MAR 2022 (Values in Cr)
Net Income 8.46
Cash from Operations 8.14
Cash from Investing -1.52
Cash from Financing -6.30
Net change in Cash 0.14
Free Cash Flow 9.66
Particulars MAR 2021 (Values in Cr)
Net Income 2.08
Cash from Operations 3.18
Cash from Investing -0.17
Cash from Financing -1.59
Net change in Cash 1.02
Free Cash Flow 3.33
Particulars MAR 2020 (Values in Cr)
Net Income 0.61
Cash from Operations 1.10
Cash from Investing -2.45
Cash from Financing 1.42
Net change in Cash 0.07
Free Cash Flow 1.21
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7873.25 71.95 13.79 113205.26 6002.15 / 7981.20
FORTIS MALAR HOSPITALS LIMITED 65.80 26.75 4.08 123.32 51.01 / 98.70
SHREE PACETRONIX LTD. 199.65 68.84 5.21 71.86 61.11 / 199.65
TRANSGENE BIOTEK LTD. 3.78 0.00 2.85 28.64 3.22 / 8.55
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7873.25 83.77 12.96 113205.26 6002.15 / 7981.20
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 40.85 0.00 -16.14 30.51 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6318.80 31.36 6.36 6912.77 4777.15 / 6525.00

3B BlackBio Dx Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1425.85 0.18 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 1427.40
  • 26 Days 1465.30
  • 10 Days 1435.30
  • 50 Days 1500.40
  • 12 Days 1439.20
  • 100 Days 1557.30
  • 20 Days 1455.10
  • 200 Days 1564.50
1425.88 PIVOT

First Support

1407.32

First Resistance

1441.72

Second Support

1391.48

Second Resistance

1460.28

Third Support

1372.92

Third Resistance

1476.12

RSI

43.45

ADX

13.76

MACD

-26.10

Williams % R

-71.92

Commodity Channel Index (CCI)

-56.67

Date

2025-09-12

Week

6459.00

Same Day

574.00

Month

7134.00

1 Year

0.58

3 Year

0.57

Over 1 Month

-8.46%

down

Over 1 Year

-1.44%

down

Over 3 Months

-10.39%

down

Over 3 Years

56.82%

down

Over 6 Months

-16.63%

down

Over 5 Years

34.18%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

3B BlackBio Dx Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
54.25%
Promoter Holdings
41.28%
FII
2.7%
DII
1.75%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Mithla Dubey 1059770.0 (12.35%) Shareholding of Promoter and Promoter Group
Mithala Laboratories Private Limited 820700.0 (9.56%) Shareholding of Promoter and Promoter Group
Dhirendra Dubey 724098.0 (8.44%) Shareholding of Promoter and Promoter Group
Rashi Daga 455070.0 (5.3%) Public Shareholding
Prateek Goel 441435.0 (5.14%) Public Shareholding
Own Infracon Private Limited 384538.0 (4.48%) Public Shareholding
Nikhil Kuber Dubey 358080.0 (4.17%) Shareholding of Promoter and Promoter Group
2b Blackbio S.l. Spain 241570.0 (2.81%) Shareholding of Promoter and Promoter Group
Maj Navraj Singh Grewal 222500.0 (2.59%) Public Shareholding
Ram Kuber Dhirendra Kumar 194700.0 (2.27%) Shareholding of Promoter and Promoter Group
Dalmus Performance Focused Fund 150284.0 (1.75%) Public Shareholding
Prajesh Maroo 135110.0 (1.57%) Public Shareholding
Shalu Aggarwal 96061.0 (1.12%) Public Shareholding
Sandeep Kapadia 86000.0 (1.0%) Public Shareholding
Rajesh Kumar Dubey 37700.0 (0.44%) Shareholding of Promoter and Promoter Group
Madhulika Dubey 29000.0 (0.34%) Shareholding of Promoter and Promoter Group
Santosh Kumar Dubey 26200.0 (0.31%) Shareholding of Promoter and Promoter Group
Mahesh Kumar Upadhyay 24250.0 (0.28%) Shareholding of Promoter and Promoter Group
Anamika Dubey 22000.0 (0.26%) Shareholding of Promoter and Promoter Group
Sanjay Kumar Dubey 5100.0 (0.06%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

3B BlackBio Dx Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2025 4.0 Final 19 Sep 2025 Equity shares
17 Sep 2024 3.0 Final 18 Sep 2024 Equity shares
15 Sep 2023 2.5 Final 15 Sep 2023 Equity shares
14 Sep 2022 2.5 Final 16 Sep 2022 Equity shares
14 Sep 2021 1.0 Final 16 Sep 2021 Equity shares
14 Sep 2021 8.0 Special 16 Sep 2021 Equity shares
19 Mar 2020 0.7 Interim 20 Mar 2020 Equity shares
17 Sep 2019 0.5 Final 19 Sep 2019 Equity shares
17 Sep 2018 0.5 Final 19 Sep 2018 Equity shares
15 Sep 2017 0.3 Final 19 Sep 2017 Equity shares
19 Sep 2011 1.0 Final 21 Sep 2011 Equity shares
18 Sep 2007 1.0 Final 20 Sep 2007 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

3B BlackBio Dx Limited Share Price

3D Blackbio DX Ltd (Formerly known Kilpest India Ltd) was incorporated on May 25, 1972, as one of India's leading Agri-based companies. Shri R.K. Dubey is the founder of this Company. It was the only pesticide formulating company in the entire region of Madhya Pradesh in 1970s. The company has now grown over the years and is leading today in Central India and manufactures about 50 pesticide products, microfertilizers, biofertilizers and biopesticides.

The Company has representation in India in the field of agriculture business comprising crop protection, public health products and bio-products and is reputed reliable supplier to various Govt. organizations, such as Directorate General of Supplies & Transport, New Delhi, NAVY, Vishakapatnam/Mumbai, Food Corporation of India Raipur/ Bhopal/ Lucknow/ Mumbai/ Jaipur, NTPC, Bilaspur, Directorate of Health Service, M.P/Maharashtra/AP, Directorate of General Of Health Organization, Gujarat/U.P, Directorate General of Health services, MOH&FW (NVBDCP), Govt. of India, M/s Hindustan Latex Ltd, Noida, Director of Agriculture and Horticulture, M.P./Trivandrum, Central/Western Railway, Mumbai, Northern Railway, New Delhi etc. the company has nationwide distribution network of over 2000 dealers.

It possess well equipped R&D laboratory duly approved and recognized by DSIR, Ministry of Science and Technology, Government of India. Advanced instrumentation facility supported by equally competent team of scientists and technicians lay down a strong R&D foundation. Clean and hygienic environment ensure the consistency and reliability of results. Laboratory studies are planned, performed, monitored, recorded, applied in small scale field and then tabulated.

The products are manufactured to high International specifications with stringent quality control from raw material procurement to finished goods dispatch. The company's manufacturing process is complimented with the technical expertise and it has attained high standard suited to customer needs on 23-7-2002. Kilpest has received accreditation of International standard ISO 9001-2000 certified company. The companyhas diversified manufacturing in the field of micronutrients, bioproducts and plant growth regulators etc. The company is also exporting its products to Bangladesh and Afghanistan.

In 2011-12, the Company launched Novel Biotech Indo-Spanish Joint Venture Project in Govindpura, Bhopal, Madhya Pradesh. It ventured into Diagnostic Service.

In June, 2020, the Company launched , its single tube multiplex assay for TRUPCR SARS-CoV-2 RTqPCR Kit (Real-Time PCR based detection of SARS-CoV-2 virus) Version 3.2. With this, 3B BlackBio Biotech India Ltd. became first ever Indian molecular diagnostics company to receive US FDA-(EUA).

In 2023, through the Scheme of Arrangement, the Holding Company, Kilpest India Ltd was merged with 3B BlackBio Biotech India Ltd and as per the Scheme of Amalgamation, the name of the Company got changed from Kilpest India Ltd to 3B BlackBio DX Ltd.

Parent organization Indian Private
NSE symbol [-]
Founded 1972
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of 3B Blackbio DX Ltd?

Answer Field

3B Blackbio DX Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 1,425.85 as on Sep 12 2025 03:30 PM.

What is the Market Cap of 3B Blackbio DX Ltd Share?

Answer Field

The market cap of 3B Blackbio DX Ltd for NSE ₹ 0.00 & for BSE ₹ 1,223.80 as on Sep 12 2025 03:30 PM.

What is the 52 Week High and Low of 3B Blackbio DX Ltd?

Answer Field

The 52 Week High and Low of 3B Blackbio DX Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 2,350.00 and ₹ 1,253.80.

What is 1 year return for 3B Blackbio DX Ltd?

Answer Field

The 1 year returns on the stock has been -1.44%.

What is the P/E Ratio of 3B Blackbio DX Ltd Share?

Answer Field

As on Sep 12 2025 03:30 PM the price-to-earnings (PE) ratio for 3B Blackbio DX Ltd share is 24.82.

What is the PB ratio of 3B Blackbio DX Ltd Share?

Answer Field

As on Sep 12 2025 03:30 PM, the price-to-book (PB) ratio for 3B Blackbio DX Ltd share is 317.85.

How to Buy 3B Blackbio DX Ltd Share?

Answer Field

You can trade in 3B Blackbio DX Ltd shares with Bajaj Broking by opening a demat account.

How to Buy 3B Blackbio DX Ltd Share on Bajaj Broking App?

Answer Field

To buy 3B Blackbio DX Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “3B Blackbio DX Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91